{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:37:20Z","timestamp":1779345440362,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000320","name":"Alzheimer's Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.brainres.2013.02.012","type":"journal-article","created":{"date-parts":[[2013,2,16]],"date-time":"2013-02-16T01:15:54Z","timestamp":1360977354000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington\u2019s disease"],"prefix":"10.1016","volume":"1504","author":[{"given":"Hsin Hsien","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri G.","family":"Gelovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Herholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.02.012_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","article-title":"Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.brainres.2013.02.012_bib2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","article-title":"Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17","volume":"442","author":"Baker","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.02.012_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686117","article-title":"Distribution of histone deacetylases 1\u201311 in the rat brain","volume":"31","author":"Broide","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2013.02.012_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders","volume":"7","author":"Butler","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2013.02.012_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1471-4159.2003.01648.x","article-title":"Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5","volume":"85","author":"Chawla","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.02.012_bib6","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.02.012_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2012.04.015","article-title":"Disruption of Purkinje cell function prior to huntingtin accumulation and cell loss in an animal model of Huntington Disease","volume":"236","author":"Dougherty","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.02.012_bib8","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.02.012_bib9","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2013.02.012_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1471-4159.2003.01991.x","article-title":"Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein","volume":"87","author":"Hoshino","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.02.012_bib11","doi-asserted-by":"crossref","first-page":"41472","DOI":"10.1074\/jbc.M307245200","article-title":"Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+)\/\/calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival","volume":"278","author":"Linseman","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.02.012_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2013.02.012_bib13","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2013.02.012_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2009.01045.x","article-title":"Review: Recent progress in frontotemporal lobar degeneration","volume":"36","author":"Pickering-Brown","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.brainres.2013.02.012_bib15","first-page":"2","article-title":"Evaluation of histone deacetylases as drug targets in Huntington\u2019s disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model","author":"Quinti","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.brainres.2013.02.012_bib16","article-title":"Degeneration of the cerebellum in Huntington\u2019s Disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","author":"Rub","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainres.2013.02.012_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720506778249407","article-title":"Histone deacetylase inhibitors: a novel therapeutic approach to Huntington\u2019s disease (complex mechanism of neuronal death)","volume":"3","author":"Sadri-Vakili","year":"2006","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.brainres.2013.02.012_bib18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington\u2019s disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2013.02.012_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/biomet\/69.3.493","article-title":"Plots of P-values to evaluate many tests simultaneously","volume":"69","author":"Schweder","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.brainres.2013.02.012_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations","volume":"135","author":"Snowden","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2013.02.012_bib21","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.brainres.2013.02.012_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:59:24Z","timestamp":1762102764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":22,"alternative-id":["S0006899313002047"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.02.012","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2013.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}